While cytokines are produced by various cells; T cells, B cells, NK cells, monocytes, vascular endothelial cells, neutrophils, and fibroblasts , neopterin is a substance of which production is limited to monocytes, B cells, kidney epithelial cells and vascular endothelial cells. Serum neopterin levels correlate well with the activation of circulating monocytes and reticuloendothelial system including vascular endothelial cells and macrophages in tissue. In the diagnosis of diseases and in the elucidation of their pathophysiology, neopterin determination appears to be a powerful and useful tool to assess the activation of monocyte-lineage cells.
Introduction
Neopterin (6-D-erythro-trihydroxypropylpterin) is a low-molecular-weight substance (MW: 253) derived from guanosine triphoshate (GTP). It circulates in the blood and is ultimately eliminated in the urine. Monocytes have been said for to be the principal cells synthesizing neopterin in vivo.
As monocytes do not possess dihydroneopterin triphosphate (NH 2 P 3 )-converting enzyme in contrast to other cells, e.g. hepatocytes, they produce neopterin from their precursor, 7,8-dihydroneopterin triphosphate, independently of the enzyme.
In hepatocytes and other cells, on the other hand, NH 2 P 3 is converted to 5,6,7,8-tetrahydrobiopterin (BH4) by NH2P3-converting enzyme. While neopterin is considered to be produced mainly by monocytes, interferon-y ( IFN-y), § Author to whom correspondence should be addressed.
Pteridines/ Vol. 7 / No. I which is produced by T cells and T-lineage cells, that is, T helper I (Th 1) cells and natural killer cells (NK cells), is a cytokine known to activate monocytes and promote neopterin production in monocytes (1) .
GTP cyclohydrolase I converts GTP to 7,8-dihydroneopterin tri-phosphate. Recently, it was disclosed that upon INF-y treatment, GTP cyclohydrolase I activity is increased 7 to 40-fold in human peripheral blood-derived macrophages, although the actual increase of GTP cyclohydrolase I activity is not observed in fibroblasts with INFy treatment (2) .
For this reason, neopterin could be regarded as a kind of marker for the activation of cellular immunity in a variety of disease. In this paper we describe our work and studies conducted elsewhere concerning neopterin production in vitro and in vivo.
Cytokines and Neopterin Figure 2 . The effect of TFN-a on neopterin production by vascular endothelial cells and monocytes. EC, vascular endothelial ce lls; mono, m onocytes.
Neopterin-producing cells
It has been suggested that when monocytes derived from peripheral blood are cultured in vitro with the addition of INF-y , monocytes vigoro usly produce neopterin and consequently, neopterin is markedly accumulated in the supernatant ( 1, 3) .
On the other hand, it has been reported that vascular endothelial cells are capable of phagocytosis and superoxide production (4) and display functions and properties very similar to those of monocytes in terms of becoming Ia antigen-posltlve after stimulation with IFN -y (5) . Considering that vascular endothelial cells might have the ability to produce neopterin as monocytes do, we conducted the experiments described below (Figs. 1 and 2 ) (3) .
Firstly, monocytes were isolated from human peripheral blood mono-nuclear cells using continuous density gradient centrifugation (Sepracell MN, Sepratech). The monocytes (5 X 10 5 Iwe ll) were cultured in 24-well plastic plate with the addition of IFN-y at a final concentration of 0 UI ml, 10 U / ml, 100 U/ml, 1,000 U/ml and 10,000 U/m !. After 24, 72, and 120 hours from the onset of the culture, the culture-supernatants were obtained and then the neopterin concentration in each supernatant was determined by the RIA (Hoechst ) (6) (Fig. 1) .
As reported previously, the neopterin levels in the culture supernatants increased depending upon both the IFN-y concentration and the culture period.
Secondly, vascular endothelial cells were collected after exposing human umbilical veins to col- lagenase. As in the experiment shown in Fig. 1 , IFN -g was added to the culture wells at final concentrations of 0 U / ml, 10 U/ml, 100 U/ml, 1, 000 U / ml and 10,000 U / m!. After 24, 72, and 120 hours from the onset of the culture, the supernatants were removed and then the neopterin in the supernatant was measured in the same manner as that used in the determination of neopterin production from monocytes. The results showed that vascular endothelial cells vigorously produce neopterin like monocytes (Fig.2) .
Andert et al reported that IFN-y stimulates endothelial cells to produce neopterin. Furthermore, when tumor necrosis factor-a (TNF-a) is added to the endothelial cell culture with IFN-y, neopterin production is highly augmented (7) .
It was revealed that neopterin is not produced by T cells, B cells, or large granular lymphocytes (LGLs) (I). We also added IFN-y, interferon-a (IFN-a) , or interleukin-l (IL-I) to fibroblasts, cultured them, and determined the amount of neopterin produced in the supernatant. No evidence of neopterin production by fibroblasts was found.
On the other hand, Hofmann el al reported that B cells activated with IFN-y or interleukin-2 (IL-2) produce neopterin, while monocytes do only with IFN -r( 8 ).
Recently, kidney epithelial cells was shown to releaseneopterin in the co-culture with INF-y (9 ). control  1  10  100  1  10 100 1,000 pg/ml pg/ml pg/ml ng/ml ng/ml ng/ml IU/ml Figure 5 . The effect of LPS on neopterin production by monocytes. Monocytes were cultured fo r 120 hours with LPS, or interferon-yo Neopterin in each supernatant was determined using RIA.
Regulation of neopterin production by cytokines in vitro
Previous studies examined the assoCIatIon of various cytokines and neopterin production from monocytes. The present authors also investigated the ability of monocytes and vascular endothelial cells to produce neopterin .
In our own experiments, neopterin production by both monocytes and vascular endothelial cells increased considerably in response to IFN-y added to the cultures, whereas only a slight increase in neopterin-production was observed with IFNa alone (Figs. 1 and 2 
) (3).
Furthermore, an addition of various concentrations of IL-l or IL-2 to monocyte-cultures did not induce any increase in neopterin production. (Fig. 3) . The addition of IL-l or IL-2 to cultures of vascular endo-thelial cells did not result in the production of neopterin, either (Fig.  4) .
However, an increase in neopterin production was elicited when lipopolysaccharide (LPS) was added to the monocyte cultures (Fig.S) . It was also demonstrated that monocytes produce neopterin when monocytes in culture are stimulated with IFN-y ( 1).
Nathan et at. stimulated monocytes with IFN-y, IFN-a, interferon -~ (IFN-~) , or granulocyte-macrophage colony-stimulating factor (GM-CSF), and consequently observed the marked production of neopterin only after stimulation with IFN -y, but only slight neopterin production with IFN -a. They also clarified that neopterin production from monocytes occurs in response to LPS stimulation (10) .
Troppmair et at. attempted to stimulate monocytes in vitro with TNF-a, TNF-~, LPS, IL-l, IL-2, or GM-CSF, but these cytokines failed to elicit any neopterin production except for LPS ( 11 ) . They observed that monocytes could induce the abundant neopterin production in response to LPS stimulation.
However, the neopterin production from monocytes with LPS was not completely suppressed by anti-IFN-y antibody. The effect of LPS on neopterin production from monocytes was considered to be probably due to direct action of LPS on monocytes themselves and an indirect action of IFN-y secondary to LPS stimulation of the lymphocytes.
On the other hand, it was reported by Iizuka et al. that neopterin production from monocytes in Table 1 . Neopterin production by monocytes and vascular endothelial cells in vitro and substances that promote the neopterin production in the cells. response to LPS was completely inhibited by anti -IFN-y antibody. They concluded that neopterin production from monocytes with LPS depended on an indirect action mediated by IFN-y ( 12 ). At present, it remains to be clarified whether this is due to a direct action of LPS on monocytes or is due to an indirect action mediated by the slight amount of IFN-y produced by lymphocytes upon LPS stimulation. Table 1 shows the substances, primarily cytokines, that are related to the production of neopterin in vitro . Henderson et al. stimulated monocytes with IL-lu, IL-l~, IL-2, IL-6, TNFa, and TNF-~, but failed to elicit any increased production of neopterin (13) .
The monocytes which were cultured for 6 days with the supernatant of lymphocytes cultured for 4 days in the presence of IFN-y, IL-l, IL-2, or IL-6 increased the neopterin production, but no increase in neopterin production by monocytes was observed using the supernatant obtained from the culture of lymphocytes to which TNF had been added . Cytokines, IL-l, IL-2, and IL-6, appear to be indirectly involved in neopterin production by monocytes (Table 1) .
Neopterin is produced and secreted in large quantities from vascular endothelial cells or monocytes in response to the action of IFN-y in vitro. A smaller, but none the less substantial, amount of neopterin is produced in vitro in response to large amounts of IFN -u. LPS also appears to be capable of increasing neopterin production.
Cytokines and neopterin in vivo
Three chronic myelocytic leukemia (CML) patients were treated with IFN-a, three renal cell carcinoma patients with IFN-y, and three hepatoma patients with TNF-u. The sequential measurements of the serum neopterin levels of these patients revealed that the neopterin levels became highly elevated in the sera of renal cell carcinoma patients treated with IFN-y . Neopterin levels increased moderately in sera of the CML patients treated with IFN-a and hepatoma patients treated with TNF-a (11).
The augmented neopterin production was observed in mixed lymphocyte cultures (MLCs) and the neopterin production in MLCs was by inhibited in the presence of anti-IFN-y antibody (11) . Recently, it was also demonstrated that the serum neopterin levels of the patients receiving transfusion of allogeneic leukocytes was remarkably elevated ( 13) .
In our studies (14) as well as in other studies (15) , serum neopterin levels have been found to rise during graft versus host disease and rejection of transplanted organs.
Serum neopterin levels have been shown to increase in septicemic shock ( 11, 16) . Large amounts of cytokines, including IL-l (17), TNF (17), IL-6 (18), and IL-8 (19) , have been found to be produced in the cerebro-spinal fluid in bacterial meningitis from the early stage of the disease.
We found markedly elevated neopterin levels in the cerebrospinal fluid in bacterial meningitis and have reported the possibility of monocyte-lineage cells becoming activated in the central nervous system (20, 21) .
When we measured cerebrospinal fluid levels of IFN-y in bacterial meningitis, we found high levels of IFN-y in about half of the patients while the IFN -y levels in the other half did not rise (unpublished data) . Since all the etiologic agents in the patients with bacterial meningitis were gram-negative bacteria, LPS could also have participated in the neopterin production in the cerebrospinal fluids as one of the contributing factors of neopterin production.
Extremely high levels of serum neopterin have been reported in virus-associated hemophagocytic syndrome (VAHS) caused by Epstein-Barr virus infection (7) . In VAHS, monocytes and macrophages appear to be tremendously activated, probably by cytokines or the Epstein-Barr virus itself (22, 23) . As a result, the activated macrophages are observed to phagocytose red blood cells in bone marrow. It is suggested that monocytes in blood and macrophages in tissue produce neopterin and secrete it into the blood stream in large quantities. Indeed the serum neopterin levels seem to accurately reflect the severity of the disease state in VAHS.
